Navigation Links
Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France
Date:3/15/2012

NEW YORK, March 15, 2012 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the Company has entered into an initial launch and training agreement for the Delcath Hepatic CHEMOSAT® Delivery System with the Institut Gustave Roussy ("IGR"), a leading European cancer center located in Villejuif, France. Under the terms of the agreement, the Company will provide the IGR with logistics and clinical training support in chemosaturation therapy using the CHEMOSAT system. The Company expects training at the IGR to begin in April 2012. Upon completion of training, the IGR will be the first cancer center to commercially utilize the CHEMOSAT system to treat patients in France.

Thierry de Baere, Director of the Department of Interventional Radiology at the Institut Gustave Roussy, added, "Research suggests that CHEMOSAT will offer us a clinically meaningful tool against cancers in the liver. We look forward to working with the Delcath team to explore the product's potential."

"This agreement obviously builds on our recent momentum in establishing initial training centers to begin the launch of CHEMOSAT in Europe, and we're pleased to be working with such a prestigious institution as the IGR to introduce the product into France," said Eamonn P. Hobbs, President and CEO of Delcath System.

About the Institut Gustave RoussyThe Institut Gustave Roussy ("IGR") is a nonprofit academic entity with global expertise in the mission to fight cancer. Based in Villejuif, France, the IGR is a wholly patient-oriented leading European Comprehensive Cancer Center belonging to the French public hospital service. Created in 1921 by the then rector of the Academy of Paris, Gustave Roussy, the IGR was joined in 1925 by the Regional Centre for the fight against cancer in the Paris suburbs. Located south of Paris on a single site, IGR employs 2
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... SAN DIEGO , Dec. 24, 2014 /PRNewswire/ ... the West, developing the proprietary Natural Killer (NK) ... announces that Dr. Patrick Soon-Shiong , NantWorks ... into a definitive agreement to purchase approximately $48 ... In connection with the investment, he will be ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, 2014 /PRNewswire/ ... biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for ... need and commercial potential, today announced that it ... shares of its common stock and Series C ... stock.  Funds under the management of QVT Financial ...
(Date:12/24/2014)... PuraMed BioScience®, Inc., (OTC Pink: PMBS), a ... healthcare products, announced it received the initial funding to ... headache relief product, for planned distribution to 1,000 medical ... , Washington State , and ... H Advanced headache relief gel formulation completed, PuraMed BioScience ...
Breaking Medicine Technology:Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3
... Breast-Specific Gamma Imaging (BSGI) has been proven to be ... carcinoma in situ (DCIS), a difficult to diagnose breast cancer. ... lesions independent of tissue density and discover very early stage ... of the Radiological Society of North America (RSNA), BSGI is ...
... Nov. 30 Covance Inc. (NYSE: CVD ) today ... Health Care Conference on Wednesday, December 2, 2009 at 1:30 p.m. ... at www.covance.com . In order to register and download ... with headquarters in Princeton, New Jersey, is one of the world,s ...
Cached Medicine Technology:Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2
(Date:12/24/2014)... Recently, iFitDress.com, a famous dress manufacturer and ... under $150 . All these items are brand new; they ... already been updated with the new range of high quality ... far. All iFitDress.com’s designs are made according to the latest ... materials. Every outfit from the company is handpicked by skilled ...
(Date:12/24/2014)... December 24, 2014 Risperdal lawsuit ( ... mass tort litigation currently underway in Pennsylvania’s Philadelphia Court ... of December 24, 2014, court documents indicate that 1,183 ... of individuals who developed gynecomastia (male breast growth) and ... the Court indicates that this represents an increase of ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 New studies reveal ... to hearing loss related depression (March 6, 2014, JAMA Otolaryngology*). ... gradual hearing loss (about 50 percent according to recent polls) ... effect on how a person feels and relates to the ... overall improvements are also made by way of:, ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Dr. Vu ... the expansion of his practice and med-spa with the ... practice’s growing list of cosmetic treatments and services. , ... into the skin,” says Dr. Ho. “As a result ... such as wrinkles, sun spots, discolorations or blemishes.” , ...
(Date:12/24/2014)... December 24, 2014 The federal ... allege the blood thinner caused life-threatening episodes of ... leadership structure for the proceeding, Bernstein Liebhard LLP ... the Court plans to select lawyers to serve ... plans on appointing a Plaintiffs’ Steering Committee, which ...
Breaking Medicine News(10 mins):Health News:Many Prom Dresses under 150 from Well-known Dress Manufacturer iFitDress.com 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 3Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 4Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 5Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 6Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3
... Gain MomentumCHICAGO, March 3 Accertify www.accertify.com ... prevention solutions to online merchants, today announced that ... a developer and marketer of scientifically formulated, premium ... blend of the Amazonian acai berry and 18 ...
... March 3 Clarient, Inc. (Nasdaq: ... testing services resource for pathologists, oncologists and the pharmaceutical ... Company has renewed, expanded and extended its senior subordinated ... (NYSE: SFE ), Clarient,s majority shareholder."In the ...
... and software testing firm for medical device makers ... Technical Report, QA Software Automation and Testing. ... software quality assurance project managers tools to analyze ... the right people to automate software quality assurance ...
... accepting entries for the 2009 HealthLeaders Media Marketing Awards Program through May ... in one of 22 categories. , ... Marblehead, MA (PRWEB) March 3, ... 2009 HealthLeaders Media Marketing Awards Program through May 29, 2009. Campaigns ...
... any room, The Flag Company, Inc.,s new ,Feel Good, Light Lenses ... spirits during this trying economical time. , ... (PRWEB) ... that has gripped the nation, the Flag Company, Inc. recently launched ...
... Women,s and Children,s Hospital (KKH) can now opt for a "non-contact" ... almost painless operation to treat uterine fibroids. , ... ... KK Women,s and Children,s Hospital (KKH) can now opt for ...
Cached Medicine News:Health News:MonaVie Chooses Accertify for Online Fraud Prevention 2Health News:Clarient Renews and Expands Mezzanine Credit Facility With Safeguard 2Health News:Clarient Renews and Expands Mezzanine Credit Facility With Safeguard 3Health News:Clarient Renews and Expands Mezzanine Credit Facility With Safeguard 4Health News:For Medical Device Makers, Full Spectrum Software Releases New Software Technical Report, QA Software Automation and Software Testing 2Health News:Entry Period Opens for the 2009 HealthLeaders Media Marketing Awards Program with 11 New Categories 2Health News:Entry Period Opens for the 2009 HealthLeaders Media Marketing Awards Program with 11 New Categories 3Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 2Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 3Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 2Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 3Health News:Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: